What type of study is this?

This is a Literature Review study.

September 10, 2025Frontiers in EndocrinologyOpen Access

Correction: A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists – a comprehensive review

View Full Paper

Ask AI

Bookmark

Advances in SGLT2 inhibitors and GLP-1 receptor agonists improve outcomes for type 2 diabetes patients.
Review covers a decade of developments in cardiovascular disease related to these therapies.
This comprehensive review summarizes the progress made over ten years in managing type 2 diabetes.
Findings indicate significant improvements in treatment options for cardiovascular disease patients with type 2 diabetes.

Comprehensive review highlights advances in SGLT2 inhibitors and GLP-1 receptor agonists for type 2 diabetes and cardiovascular disease.

No takes yet. Share an insight, caveat, or question.

Aristizábal-Colorado et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark